Clinical trial
Efficacy of Intravenous Sub-Dissociative Ketamine Versus Intravenous Morphine in Children With Acute Pain
NCT06835504 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Intravenous Sub-Dissociative Ketamine Versus Intravenous Morphine in Children With Acute Pain
- Lead sponsor
- Columbia University
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- October 16, 2026
- Completion date
- April 23, 2030
- Enrollment
- 1,010 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
abdominal pain, isolated extremity fracture, pain, pediatrics